Related Experiment Video
Updated: Feb 8, 2026

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
Update on multiple endocrine neoplasia Type 1 and 2
Abdallah Al-Salameh1, Camille Baudry2, Régis Cohen3
1Hôpital Bicêtre, Assistance publique-Hôpitaux de Paris, centre de recherche clinique et service d'endocrinologie et des maladies de la reproduction, 78, rue du Général-Leclerc, 94270 Le Kremlin-Bicêtre, France.
Multiple endocrine neoplasia (MEN) syndromes, including MEN1 and MEN2, require vigilant screening and early intervention. Early detection of tumors and genetic mutations is crucial for effective management and improved patient outcomes in these rare genetic disorders.
Area of Science:
- Endocrinology
- Genetics
- Oncology
Background:
- Multiple endocrine neoplasia type 1 (MEN1) and type 2 (MEN2) are rare genetic syndromes.
- MEN1 involves tumors of the parathyroid, pancreas, pituitary, adrenals, and neuroendocrine system.
- MEN2 is characterized by medullary thyroid carcinoma, pheochromocytoma, and hyperparathyroidism.
Purpose of the Study:
- To outline screening and management strategies for MEN1 and MEN2.
- To emphasize the importance of early tumor detection and genetic testing.
- To highlight the role of multidisciplinary care and patient involvement.
Main Methods:
- Biochemical and imaging screening for MEN1.
- Genetic testing for MEN1 and RET gene mutations in MEN2.
- Prophylactic thyroidectomy for children with aggressive RET mutations.
- Surgical intervention upon diagnosis for clinical MEN2.
- Monitoring of tumor progression, particularly duodenopancreatic and thymic neuroendocrine tumors in MEN1.
- Utilizing calcitonin and CEA as tumor markers for MEN2.
Main Results:
- Screening detects tumors and monitors progression in MEN1.
- Prophylactic thyroidectomy prevents medullary thyroid carcinoma in at-risk children.
- Calcitonin and CEA levels correlate with tumor size and predict cure in MEN2.
- Doubling time of calcitonin or CEA is a significant prognostic indicator in MEN2.
- Early detection of thymic neuroendocrine tumors in MEN1 is critical due to their lethality.
Conclusions:
- Regular screening and timely interventions are vital for managing MEN1 and MEN2.
- Genetic counseling and prophylactic measures significantly improve outcomes.
- Multidisciplinary team approaches and adherence to guidelines are essential for optimal patient care.
- Patient education and participation in decision-making enhance treatment effectiveness.
Related Concept Videos
Endocrine Signaling
Predicting Products: SN1 vs. SN2
With increased substitution on the alkyl halide,...
What is the Endocrine System?
The Endocrine System
An Overview of the Endocrine System
The endocrine system collaborates...
Structures of the Endocrine System

